Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.48 |
| ▸ | RELA | Q04206 | 1/20 | 0.48 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 2/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.42 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30802459 | 1.00 | AKT1 (0.49) | AKT1SIGMAR1MAPK1MAPTNPC1 | |
| SCHEMBL27227414 | 0.87 | SIGMAR1 (0.44) | AKT1SIGMAR1MAPTAAK1PARP1 | |
| SCHEMBL27227755 | 0.87 | SIGMAR1 (0.57) | SIGMAR1MAPK1MAPTNPC1NFKB1 | |
| SCHEMBL30905656 | 0.86 | AAK1 (0.43) | AKT1SIGMAR1MAPK1MAPTAAK1 | |
| SCHEMBL27227094 | 0.86 | AAK1 (0.43) | AKT1SIGMAR1MAPK1MAPTAAK1 | |
| SCHEMBL27227030 | 0.86 | PRKAA2 (0.46) | AKT1SIGMAR1AAK1PARP1PARP2 | |
| SCHEMBL30905662 | 0.86 | PRKAA2 (0.46) | AKT1SIGMAR1AAK1PARP1PARP2 | |
| SCHEMBL27226835 | 0.85 | SIGMAR1 (0.46) | AKT1SIGMAR1MAPK1PARP1PARP2 | |
| SCHEMBL30802389 | 0.85 | SIGMAR1 (0.46) | AKT1SIGMAR1MAPK1PARP1PARP2 | |
| SCHEMBL13600191 | 0.84 | MAPT (0.51) | MAPK1MAPTNPC1NFKB1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239797-A1 | AKT1 MODULATORS | ALTEROME THERAPEUTICS, INC. | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239797-A1 | AKT1 MODULATORS | AKT1S1, AKT1, AKT2 | AKT1 2/4885SIGMAR1 4555/4885MAPK1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.